Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: La...

FDA Recall #D-0112-2025 — Class II — October 25, 2024

Recall #D-0112-2025 Date: October 25, 2024 Classification: Class II Status: Terminated

Product Description

Lisdexamfetamine Dimesylate Capsules, 10 mg, 100 Capsules per bottle, Rx only, Distributed by: Lannet Company, Philadelphia, PA 19136, NDC: 0527-4661-37

Reason for Recall

Failed Content Uniformity Specifications: Product failed to meet the action limits for stratified content uniformity.

Recalling Firm

Lannett Company Inc. — Seymour, IN

Classification

Class II — May cause temporary or medically reversible adverse health consequences.

Product Type

Drugs

Product Quantity

1608 bottles

Distribution

Nationwide in the USA

Code Information

Lot: 23274856A, Exp 04/30/2025

Status

Terminated

Voluntary / Mandated

Voluntary: Firm initiated